Arthritis Research & Therapy

official impact factor 4.36

Open Access

Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays

Bert Vander Cruyssen*, Tineke Cantaert, Leonor Nogueira, Cyril Clavel, Leen De Rycke, Amélie Dendoven, Mireille Sebag, Dieter Deforce, Christian Vincent, Dirk Elewaut, Guy Serre and Filip De Keyser

Arthritis Research & Therapy 2006, 8:R122 doi:10.1186/ar2011

Accesses  

  • Last 30 days: 42 accesses
  • Last year: 548 accesses
  • All time: 3600 accesses

Cited by

BioMed Central: 3 citations

Review   Free

The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis

Ger JM Pruijn, Allan Wiik, Walther J van Venrooij Arthritis Research & Therapy 2010, 12:203 (15 February 2010)

Research article   Open Access Highly Accessed

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis

Raimon Sanmartí, Eduard Graell, Maria L Perez, Guadalupe Ercilla, Odette Viñas, Jose A Gómez-Puerta, Jordi Gratacós, Alejandro Balsa, Maria J Gómara, Marta Larrosa, Juan D Cañete, Isabel Haro Arthritis Research & Therapy 2009, 11:R135 (2 September 2009)

Research article   Open Access Highly Accessed

Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis

Xiaoyan Zhao, Nwora Okeke, Orr Sharpe, Franak M Batliwalla, Annette T Lee, Peggy P Ho, Beren H Tomooka, Peter K Gregersen, William H Robinson Arthritis Research & Therapy 2008, 10:R94 (18 August 2008)